Expanding Access to Immunotherapy in the Community Setting
As patient and provider interest in immuno-oncology treatment options grows, only a few are FDA-approved. To expand immunotherapy treatment access across their network of rural cancer centers, Sanford Health established a comprehensive research program that uses weekly tumor-specific video conferences and multidisciplinary molecular tumor boards to evaluate patients for clinical trial eligibility and immunotherapy treatment options. Learn how system-wide virtual conferences can serve as an important decision-making tool to expand access to immunotherapy.